Closing the gaps in cervical cancer prevention and treatment through innovation
Twenty years after the approval of the first HPV vaccine, a game-changing tool that has helped dramatically reduce rates of HPV infection and cervical cancer around the world, researchers are now developing new tools to address remaining gaps in cervical cancer screening, diagnosis, and care.